Advances in Nanobiotechnology-Propelled Multidrug Resistance Circumvention of Cancer
Jie Chen,Xin Yu,Xinyu Liu,Jinliang Ni,Guangcan Yang,Kun Zhang
DOI: https://doi.org/10.1039/d2nr04418h
IF: 6.7
2022-08-30
Nanoscale
Abstract:Multidrug resistance (MDR) is one of the main reasons leading to the failure of tumor chemotherapy and affecting the therapeutic effect. There are two main causes of MDR: The first refers to the activation of efflux pumps for drugs, which can transport intracellular drug molecules from cells; Another mechanism is associated with non-efflux pumps, e.g., apoptosis prevention, strengthened DNA repair, and strong oxidation resistance. In recent years, nanodrug delivery systems have attracted wide attentions, showing some unparallel advantages such as drug targeting and reduced drug efflux, drug toxicity and side effects in reversing MDR. It is worth mentioning that, based on the drug delivery platform of nanotechnology, multiple therapeutic strategies are integrated into one system, which can compensate their personal shortcomings. In this review, the mechanisms of tumor MDR, common vectors and nanocarriers-combined therapy strategies to reverse MDR were summarized to promote the understanding of the latest progress in improving the efficiency of chemotherapy and synergistic strategies. Especially, the adopted nanotechnology was highlighted, and the the underlying principles were shed light on, which are expected to provide guidances to promote the development of more effective anticancer strategies.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry